Tuesday, September 1, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Business

Moderna’s stock doubles on promising cancer-vaccine results

MarketWatch ·
Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Read the full article on MarketWatch ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.marketwatch.com — the content belongs to MarketWatch.

More from MarketWatch

See all ›

More in Business

See all ›